155.52
前日終値:
$155.73
開ける:
$155.27
24時間の取引高:
2.48M
Relative Volume:
1.01
時価総額:
$44.24B
収益:
$21.92B
当期純損益:
$1.76B
株価収益率:
25.40
EPS:
6.1223
ネットキャッシュフロー:
$2.63B
1週間 パフォーマンス:
-1.00%
1か月 パフォーマンス:
-2.41%
6か月 パフォーマンス:
-16.73%
1年 パフォーマンス:
-23.03%
Becton Dickinson Co Stock (BDX) Company Profile
Compare BDX vs ISRG, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
|
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 再開されました | Goldman | Neutral |
| 2026-02-10 | 再開されました | Barclays | Overweight |
| 2026-02-03 | 再開されました | Citigroup | Buy |
| 2025-09-25 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-05-02 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-07-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-05-05 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-12-12 | アップグレード | Citigroup | Sell → Neutral |
| 2022-07-11 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-06-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 再開されました | Raymond James | Mkt Perform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 再開されました | Goldman | Buy |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-07 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-02-07 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-01-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-05-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 開始されました | Deutsche Bank | Buy |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-06-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-04-10 | アップグレード | Citigroup | Neutral → Buy |
| 2018-01-19 | 再開されました | BofA/Merrill | Buy |
| 2018-01-05 | アップグレード | Citigroup | Sell → Neutral |
| 2018-01-05 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2017-12-29 | 繰り返されました | Deutsche Bank | Buy |
すべてを表示
Becton Dickinson Co (BDX) 最新ニュース
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $175 - 富途牛牛
Becton Dickinson And Co: A $5.3 Billion Quarter Signals Limited Growth Momentum - Smartkarma
Goldman Sachs Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $167 - 富途牛牛
Market Crash: The Healthcare Stocks I'd Buy Without Hesitation - The Motley Fool
Becton, Dickinson and Company (BD) 8-K Filing April 2026 – Company Details, Registered Securities, and Contact Information - Minichart
Becton, Dickinson and Company (BDX) Announces Executive Retireme - GuruFocus
Rick Byrd to Retire from BD - Finviz
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Richard E. Byrd to Retire as President of Interventional at Becton Dickinson - TradingView — Track All Markets
After 25 years at BD, a top medical device executive will retire - Stock Titan
Becton, Dickinson and Company (BDX) Stock Price, News, Quote & History - Yahoo! Finance Canada
For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD PureWick Urine Collection System - Finviz
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $202 - 富途牛牛
Becton Dickinson & Co. stock rises Wednesday, still underperforms market - MarketWatch
Deals tracker: Orlando Health to acquire Alabama health system - Modern Healthcare
Becton Dickinson (BDX) Pursues CE Mark for Liverty TIPS Stent Gr - GuruFocus
BD Delivers Next-Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union - Finviz
BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union - PR Newswire UK
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $198 - 富途牛牛
Becton Dickinson and Company Launches HemoSphere Stream Module - marketscreener.com
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $221 - 富途牛牛
Becton, Dickinson and Company (BDX) stock price, news, quote and history - Yahoo Finance UK
When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight - Finviz
BD Launches HemoSphere Stream Module for Continuous Blood Pressure Monitoring - Intellectia AI
BD Launches HemoSphere Stream™ Module for Continuous Non-Invasive Blood Pressure Monitoring - Intellectia AI
Rep. Kevin Hern Sells Becton, Dickinson and Company (NYSE:BDX) Shares - MarketBeat
BDX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Becton, Dickinson and Company (NYSE:BDX) Given Average Rating of "Hold" by Analysts - MarketBeat
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch
HF Advisory Group LLC Has $6.64 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Position Reduced by Trust Co. of Vermont - MarketBeat
BD Launches AI-Enabled Medication Dispensing System to the European Market - Finviz
European hospitals get BD AI medication cabinets in 15 languages - Stock Titan
List of 36 Acquisitions by Becton Dickinson (Apr 2026) - Tracxn
Becton Dickinson & Co. stock rises Tuesday, still underperforms market - MarketWatch
Fairleigh Dickinson University Appoints Cybersecurity Leader Miguel A. Crespo to Board of Trustees - Fairleigh Dickinson University
Pacific Capital Partners Ltd Buys 8,250 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Short Interest Down 16.8% in March - marketbeat.com
Accurate Wealth Management LLC Trims Position in Becton, Dickinson and Company $BDX - MarketBeat
Generate Investment Management Ltd Buys Shares of 65,000 Becton, Dickinson and Company $BDX - MarketBeat
Exchange Traded Concepts LLC Purchases 46,773 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Avity Investment Management Inc. Acquires 11,186 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Feld, Becton Dickinson & Co EVP, sells $11k in stock - Investing.com Australia
BD reports lower CEO pay but increases for other execs and the median worker - Medical Design & Outsourcing
-1.82% for Becton Dickinson stock as price nears 52-week low on persistent selling - Traders Union
How Becton Dickinson’s Medtech Pivot And Surgiphor FDA Clearance At BDX Has Changed Its Investment Story - simplywall.st
Becton Dickinson Co (BDX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):